The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials*

Henry Krum, Ingrid Hopper

Research output: Contribution to journalEditorialOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)615-617
Number of pages3
JournalJACC: Heart Failure
Volume3
Issue number8
DOIs
Publication statusPublished - 1 Aug 2015

Keywords

  • Beta-blockers
  • Clinical trials
  • Endpoints
  • Mortality

Cite this